PMGC HOLDINGS INC. Shareholders' Equity
PMGC HOLDINGS INC. (ELAB) had Shareholders' Equity of $16.74 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $16.74M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $12.61M; Stockholders' Equity Attributable to Parent as first filed $12.61M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $7.84M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $8.49M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $16.74M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $12.61M 10-Q · filed 2026-08-14 | $12.61M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $7.84M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $8.49M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $9.05M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $8.13M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $6.66M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $8.56M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $2.64M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $2.49M 10-Q · filed 2025-08-13 | |
| 2023-12-31 | $3.83M 10-K · filed 2026-03-30 | |
| 2023-09-30 | -$163.90K 10-Q · filed 2024-11-14 | -$163.90M 10-Q · filed 2023-12-11 |
| 2023-06-30 | $67.29K 10-Q · filed 2024-11-14 | $67.29M 10-Q · filed 2023-12-11 |
| 2023-03-31 | $913.39K 10-Q · filed 2024-08-14 | |
| 2022-12-31 | $1.13M 10-K · filed 2025-03-28 | $1.13B 10-Q · filed 2023-12-11 |
| 2022-09-30 | $1.62B 10-Q · filed 2023-12-11 | |
| 2022-06-30 | $145.81M 10-Q · filed 2023-12-11 | |
| 2021-12-31 | $450.63K 10-K · filed 2024-03-29 | $450.63M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |